Skip to 0 minutes and 9 secondsWelcome. Here you will learn more about the aims and benefits of the global PPS of anti-microbial consumption and resistance. The worldwide global point prevalence survey on antibiotic consumption and resistance. What is it all about? It's about data collection on antibiotic prescription patterns and resistance in the hospital. It's about comparing data, nationally and worldwide. It's about identifying targets to improve antibiotic prescribing in your hospital. What are the critical benefits of a PPS for the hospital and its patients? A PPS helps you to evaluate antimicrobial prescribing practices in your hospital, to identify targets to improve the quality of antimicrobial prescribing in your hospital, and to design hospital interventions in order to promote prudent antimicrobial prescribing.

Skip to 1 minute and 14 secondsThe first global PPS was conducted in 2015. In total, 335 hospitals from 53 different countries participated. The bigger the dot, the more hospitals participated for that country. You can see here that most hospitals originated from European countries, but also several hospitals participated from America, Asia, Africa, as well as Australia and New Zealand. Let us now look at some more key benefits of the global PPS. We'll give you four of them. The first one-- the global PPS allows meaningful comparisons of antimicrobial consumption data. The global PPS offers a simple and standardised protocol as well as an in-house built, freely available web based tool for data entry and validation.

Skip to 2 minutes and 15 secondsThe standardised protocol and web-based tool renders the surveillance feasible and achievable to complete. Next, there is the quality assurance approach to the implementation of the data validation process. In order to achieve all of this, there is a central support towards data collection or other help participants might need. The helpdesks answers emails in a timely manner. There is a frequent asked questions list, an IT manual, et cetera, to support participants. The global PPS and its web-based programme allows repeated PPSs in time. A search, implemented interventions and actions at the local level in the hospital, can be assessed in order to evaluate whether antibiotic prescribing practices in hospitals improved in time. As you'll see, this tool allows consistency and reproducibility in time.

Skip to 3 minutes and 23 secondsThe next key benefit for participants is that they receive real time feedback of their results. Participants provide efforts in collecting data. The collection of meaningful data is only valuable whenever local hospital data can be compared to other hospitals, other settings, or other regions. Whenever the data are entered and subsequently validated online onto the freely available global PPS programme, participants are able to download a comprehensive feedback, which compares hospital results to average results for the country, if at least three hospitals participated for that country. Next, the hospital results are compared to the region, as well as to average results for Europe. Here you see some examples. Feedback is provided through tables and graphs, such as bar charts and pie charts.

Skip to 4 minutes and 28 secondsThe next key benefit is networking, which is needed to achieve our common goals. The global PPS provides an opportunity to stimulate local networking. Of course, mutual cooperation and feedback is highly motivating for all partners. Further, through networking, we will continually improve health care quality. All together, we need to fight against antibiotic resistance and work towards improved antibiotic use for better patient healths. Indeed, this global PPS enhances sustained awareness. A last key benefits refers to the possibility to perform research, including hypothesis formulation. The global PPS enables in-depth interpretation of antimicrobial consumption data at different levels-- geographical, institutional, and patient level. The global PPS enables the creation of a reference database for scientific research and hypothesis formulation at national and international level.

Skip to 5 minutes and 47 secondsYes, we encourage participants to work with their data. We further encourage data sharing in order to investigate specific research questions. For example, regarding haemato-oncology patients. Of course, data sharing is only done upon agreement with all partners. Further, we stimulate writing of abstracts, reports, scientific, peer-reviewed manuscripts. We need to share knowledge. If you are interested in your publication policy, please contact us on the email available at the end of this slide set. Are you convinced about the benefits for your hospital, for your patients, for yourself? This PPS method is simple and feasible. Participants to the 2015 global PPS were enthusiastic, as you can read here.

Skip to 6 minutes and 47 secondsSomeone from Saudi Arabia says, "Definitely, I will participate especially after we applied antimicrobial stewardship in a hospital, and this will give us comparative data before and after the intervention. This will be the third survey from my hospital." Someone else from Belgium reported, "We just conducted a global PPS study. All patients have now also been entered into the database. We wanted to thank the helpdesk for their cooperation. As such, the study could run very smoothly."

Skip to 7 minutes and 28 secondsAnd read the following testimonial from Serbia, a country in South Europe. "We followed your advice and made a survey team. And it was such a nice opportunity for us to develop a nice interaction to further develop our extremely good cooperation. It was extremely useful that we surveyed to get most of the wards. It was easier than we expected. Staff were very collaborative and efficient, and we were very surprised how well it was achieved. Having in mind that we did not opt to distribute posters and other stuff. It seems that people liked and welcomed our action. We hope that we will continue to collaborate with you. We are looking forward for any kind of collaboration." You are convinced?

Skip to 8 minutes and 24 secondsYou're welcome to join us. Any hospital worldwide is welcome to participate. Together, we'll fight against antimicrobial resistance.

Global PPS

Global PPS

As the article in Step 1.4 and the video in Step 1.5 explained, antimicrobial resistance is a global problem. Therefore, the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance has been developed. The Global PPS is unique in the sense that it provides additional information about microbiology and resistance rates.

This ambitious project is running now. The project runs from January to end November 2017.

The recommended dataset has been developed from the core data collected in the ESAC and ECDC European PPS.

More information on the Global PPS is available here.

The Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (GLOBAL-PPS) is an ambitious project collecting data at a global level to monitor rates of antimicrobial prescribing in hospitalised patients. The project is funded by bioMérieux.

This GLOBAL-PPS establishes a global network for point prevalence surveys and aims to include as many hospitals from as many countries from all continents. The proposed PPS will create global awareness about antibiotic use and resistance and will be instrumental in planning and supporting national and local stewardship interventions in a range of resource and geographical settings.


Why not try using the Global PPS form to collect data on a single patient (page 3) or your ward (page 2)?

Have a look at an example of a completed form to help you get started.

Would you like to join the Global PPS?

If you would like to take part in the 2017 Global PPS, please see the protocol to learn more. You will find data protection information on page 8.

You can sign up for the 2017 Global PPS directly here.

Below, we provide a summary of Global Point Prevalence Survey of Antimicrobial Consumption information.


The Global-PPS aims to expand the standardised surveillance method of data collection that can be used at a global level, in order to: (1) to determine the variation in drug, dose and indications of antimicrobial prescribing in hospitalised patients across all continents (2) to collect information on the prevalence of resistance in hospitals across all continents (3) to improve the quality of antibiotic prescribing for adults and children admitted in hospitals across the world (4) to reduce the prevalence rates of antimicrobial resistance in bacterial infections.

Data privacy

A sequence number will be assigned to each hospital after registration to the Global PPS program. Hospital names will never be revealed in any report or publication

Patients are completely anonymised in the Global PPS program. Every patient record will be given a unique, not identifiable, survey number. This number is automatically generated by the computer program based on several internal codes. This number identifies uniquely the patient in the Global PPS database.

Data collection

Data is collected by each participating hospital on paper forms. These data are entered on-line using the Global –webPPS program.

Data ownership

Each participant to the Global PPS remains the owner of his/her own data, and can only access their own data. Data are the property of their respective hospital.

Data protection

The Coordinating Center & Technical Support team at the University of Antwerp, Belgium is the guardian of the data within the database.

There is only one master copy of the Global PPS data files and the Global PPS leader acts as guardian of this which is stored on the ESAC server based at the University of Antwerp, Belgium.

Publication policy

The Global PPS leader is responsible for dissemination of Global results and support of opportunities for authorship.

The full Global PPS Protocol and Publication Policy are available in “Downloads” below.

Share this video:

This video is from the free online course:

Challenges in Antibiotic Resistance: Point Prevalence Surveys